Showing 2721-2730 of 19323 results for "".
Early Referral in PMR Management and the Impact on Outcomes
https://reachmd.com/programs/medical-industry-feature/early-referral-in-pmr-management-and-the-impact-on-outcomes/32971/TBDSilent Brain Damage in ATTR-CM: Exploring Neurological Impacts
https://reachmd.com/programs/spotlight-attr-cm/silent-brain-damage-in-attr-cm-exploring-neurological-impacts/32418/ATTR-CM patients can experience brain damage with no apparent symptoms. Read about a recent study on this concerning phenomenon.Cannabis Extract and Melanoma: Insights into Cell Death Mechanisms
https://reachmd.com/programs/dermconsult/cannabis-extract-and-melanoma-insights-into-cell-death-mechanisms/17998/Researchers have started looking into how a Cannabis sativa extract, called PHEC-66, could trigger cell death in melanoma cells.Sniffing Out the Problem: A Dive into Management for Chronic Rhinosinusitis with Nasal Polyps
https://reachmd.com/programs/cme/sniffing-out-problem-dive-management-chronic-rhinosinusitis-nasal-polyps/11071/For the 20% of patients with chronic rhinosinusitis who develop nasal polyps, identifying the underlying cause is essential for treatment.MIRASOL Insights in PROC: A Biomarker-Driven Approach
https://reachmd.com/programs/project-oncology/mirasol-proc-biomarker-approach/37252/In platinum-resistant ovarian cancer (PROC), survival is usually measured in months,1-3 and most patients will have already received multiple prior lines of therapy.4 Biomarker-driven therapy has helped change the treatment landscape.5-10 Tune in to learn more about mirvetuximab soravtansine-gynx asIdentification, Management, and Prevention of Polypharmacy in Multiple Sclerosis
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/identification-management-and-prevention-of-polypharmacy-in-multiple-sclerosis/32088/Rational prescription practices in multiple sclerosis treatment are key to the prevention and mitigation of polypharmacy.Tirzepatides & Therapeutic Inertia: Highlights from ADA
https://reachmd.com/programs/ada-action-center/tirzepatides-therapeutic-inertia-highlights-from-ada/13757/Dr. Carol Wysham shares highlights from the ADA’s 82nd Scientific Sessions.Cytomegalovirus and Herpes Simplex Virus Coinfection Neuroretinitis in an Immunocompetent Individual
https://reachmd.com/programs/practical-neurology/cytomegalovirus-and-herpes-simplex-virus-coinfection-neuroretinitis-in-an-immunocompetent-individual/32179/The authors describe the process of distinguishing neuroretinitis from optic neuritis and vasculitis.Quality of Life for Older People With Epilepsy
https://reachmd.com/diseases-diagnoses/epilepsy-seizures/quality-of-life-for-older-people-with-epilepsy/32178/Focusing on all aspects of health and well-being when treating older adults with epilepsy is important for improving quality of life.Addressing CKM Mortality & Morbidity in Patients With CKD and T2D: The Role of Combined ns-MRA & SGLT2i Therapy
https://reachmd.com/programs/cme/addressing-ckm-mortality-morbidity-in-patients-with-ckd-and-t2d-the-role-of-combined-ns-mra-sglt2i-therapy/29907/Insights on CKD and T2D care: Experts explore CONFIDENCE trial results, combination therapy, and collaborative CKM care to reduce cardio-kidney risk.